CaptiView is a microscope image injection system that overlays critical virtual reality imaging directly onto the brain when viewed through the eyepiece during surgery. This new microscope technology allows images of chosen objects, including original CT, MRI and angiogram datasets, to be superimposed, or 'injected,' directly into the neurosurgeon's eyepiece during microscopic surgery.
As the Turkish government restores order after the failed coup, the American Association for the Advancement of Science and seven other leading science and engineering societies today expressed concern for the human rights of the Turkish scientific community, which has reportedly been subject to restrictions including travel bans and the ordered return of Turkish academics working abroad.
The University of Adelaide and global organization Conservation International (CI) today announced a strategic partnership that will help boost conservation efforts in the Asia-Pacific region, including a global conservation drone program.
At the University of Missouri, initiatives within the financial aid office, backed by new research from the Truman School of Public Affairs, are showing that establishing relationships, more than merely providing information, is important when helping students make better financial decisions.
Valley Fever, a potentially deadly dust-borne fungal disease, should be easier to diagnose and treat thanks to a testing technology developed by the Translational Genomics Research Institute (TGen) and Northern Arizona University (NAU), and now protected by a patent issued today by the US Patent and Trademark Office. TGen and NAU have exclusively licensed this technology to DxNA LLC, which plans to make this Valley Fever Test commercially available to hospitals and clinics this year.
Ten years in the making, a new NASA instrument would measure atmospheric carbon dioxide, a greenhouse gas, with laser accuracy -- literally.
Oxford University Press (OUP) has signed an agreement with the American Society of Comparative Law (ASCL) to publish the American Journal of Comparative Law (AJCL), the leading journal in the field, from January 2017.
Griffith University will partner with a Chinese pharmaceutical, Olymvax Biopharmaceuticals Inc. for a new vaccine that could benefit millions. Researchers from Griffith University's Institute for Glycomics have announced that they will begin Phase 1 clinical trials on a new, needle-free vaccine targeted at Streptococcus A infection, the cause of strep throat and rheumatic heart disease.
Adis, a leading global provider of drug information, is launching a new open access pharmacoeconomics journal, which will be added to their portfolio in 2017. Called PharmacoEconomics - Open, the new journal will focus on cost and health outcomes associated with drugs, devices and other healthcare interventions. PharmacoEconomics - Open has the same co-editors as Adis's flagship journal in the field, PharmacoEconomics.
PharmaMar today announced the start of a pivotal Phase III ATLANTIS study evaluating efficacy and safety of PM1183 in combination with doxorubicin versus topotecan or the combination VCR in patients with small cell lung cancer after the failure of one prior platinum-containing line.